Sept 30 (Reuters) - Abbvie Inc ABBV.N :
* ALLERGAN INC.- WORKING CLOSELY WITH HEALTH CANADA TO VOLUNTARILY WITHDRAW FIBRISTAL(®) (ULIPRISTAL ACETATE TABLETS, 5 MG) ACROSS CANADA
* ALLERGAN- REVIEWED BENEFITS, RISKS FOR FIBRISTAL FOLLOWING REPORTS OF RARE CASES OF SEVERE LIVER INJURY REQUIRING LIVER TRANSPLANTATION IN EUROPE
* ALLERGAN - HAS DECIDED TO REMOVE MEDICATION FROM CANADIAN MARKET